Pharmaceuticals & Health Care Research

Indonesia / Healthcare /  Pharmaceuticals & Health Care Research

The Pharmaceuticals & Health Care Research subsector on the Indonesia Stock Exchange encompasses companies involved in the pharmaceuticals industry. This subsector plays a major role in Indonesia's market due to several factors. Firstly, the country's growing population and increasing healthcare needs create a significant demand for pharmaceutical products. Additionally, the government's focus on improving healthcare infrastructure and expanding access to healthcare services further drives the growth of this subsector. Moreover, Indonesia's potential as a hub for pharmaceutical research and development attracts both domestic and international companies, leading to increased investments and advancements in the industry. At this moment, this sub-sector appears to be in a bearish market sentiment, with a total market cap depreciation of approximately -25% over the past 365 days. It's possible that around 9 companies within this sub-sector may have encountered a negative market cap change, while it seems that only about 2 companies might have experienced a positive market cap change, indicating a challenging market environment. Notable companies in this subsector, based on market capitalization, include Kalbe Farma Tbk, PT Industri Jamu Dan Farmasi Sido Muncul Tbk, Tempo Scan Pacific Tbk, PT Soho Global Health Tbk, and Kimia Farma Tbk.

P/E Value

The Pharmaceuticals & Health Care Research sub-sector is generally considered defensive due to the consistent demand for healthcare products and services regardless of economic conditions. Historically, the P/E values for this sub-sector have been moderate, reflecting steady growth prospects. The current lower P/E values compared to last year may be influenced by factors ...

8.62

Price to Earnings

Pharmaceuticals & Health Care Research Sector P/E
8.62
The Price-to-Earnings (P/E) ratio is a key tool for investors and analysts to assess whether a stock is overvalued, undervalued, or fairly valued. The P/E ratio is calculated by dividing the market price of a company's stock by its earnings per share (EPS).
Pharmaceuticals & Health Care Research Weighted Sector P/E
17.71
The weighted average P/E ratio is a measure of the average P/E ratio of the companies in the sector, weighted by market capitalization.
Indonesia Stocks Avg. P/E
8.22

Resilience & Health Index

In the Pharmaceuticals & Health Care Research sub-sector, out of 13 companies, 8 placed in the sub-sector ranking based on price changes in the previous 30 days, outperforming IDX. This could be due to the sector's resilience to market fluctuations and high demand for healthcare products. With no new listing companies this month and barriers to entry, such as strict ...

7.6

Sector Health Score

Pharmaceuticals & Health Care Research Sector Max Drawdown
-0.35
The maximum drawdown is the maximum loss from a peak to a trough of a portfolio, before a new peak is attained. Maximum Drawdown (MDD) is an indicator of downside risk over a specified time period.
Indonesia Stocks Avg. Max Drawdown
-0.26
Pharmaceuticals & Health Care Research RSD (Close)
0.13
The RSD (Close) is a measure of the volatility of a stock's daily price change. It is calculated as the standard deviation of each day's logarithmic returns summed over the past 90 days.
Indonesia Stocks Avg. RSD (Close)
0.14

Key Figures

Pharmaceuticals & Health Care Research companies on IDX

13

Total Market Cap. (IDR, billion)

IDR 115,802.90B

0.97% of total market cap. on IDX
Range of P/E Value

-109 - 24

Average of 8.6 P/E
Sector CAGR

> 0%

Compound Annual Revenue Growth of -4.32%

Pharmaceuticals & Health Care Research Sector Performance

IDR 115.80T

Sector Market Cap. (IDR, trillion)
  1. Last 4 Quaters

  2. Prev 4 Quarters

Sector Composition

Sector Valuation

Historical valuation of companies in Pharmaceuticals & Health Care Research
More than 5% deviation of median from the last 3 years
Within 5% deviation of median of last 3 years
TTM: Trailing Twelve Months (TTM)
Metric202020212022Current (TTM)
Price/Equity25.3820.5811.838.62Lower than average of last 3 years
Price/Book2.852.421.891.18Lower than average of last 3 years
Price/Sales1.881.140.940.75Lower than average of last 3 years
Price/Cash Flow20.419.8118.665.16Lower than average of last 3 years

Executive Summary

Sector Performance

1W

+5.9%

1Y

-23.1%

YTD

-3.7%

Trailing 12 Months

Overall -23.1%

−0.06−0.04−0.020.02

Positive

Neutral (Within <2.5%)

Negative

Sector Percentile

18%

35
55
75
0
100

This sector has a return that beats 18% of all sectors on the Indonesia Stock Exchange over the past 12 months.

Sector Dividend Yield

6.93%

Dividend-paying companies in this sector pay out a dividend yield of 6.93% on average over the past 12 months. This beats the average dividend yield of all companies on IDX, which is around 3.23%.

Sector Stabillity

86%

35
55
75
0
100

This sector is comparably stable, with a RSD (Relative Standard Deviation) of 13%. Companies on IDX have an average RSD of 12%. This gives the sector a score of 86%.

RSD (Relative Standard Deviation)
86%
The relative standard deviation, caluclated from the S.D of the sector's returns.
Max Drawdown
-35.27%
The maximum loss from a peak to a trough during a specific period (TTM).

This past month

Over the last month, stocks in the Pharmaceuticals & Health Care Research sector has remained flat, although notably Kimia Farma Tbk. has gained 12.12% in the last month.

Current quarter

This quarter, the sector has seen an average revenue decline of -4.32% compared to the same quarter last year.
When it comes to earnings, the sector has seen an average decline of -56.36% compared to the same quarter in 2023. Much of this growth is driven by the following companies:
SCPI.JK(+50.7%), SOHO.JK(+8.7%), MERK.JK(+4.7%), TSPC.JK(+4.2%), KAEF.JK(+2.2%).

Last 12 Months

Companies in the Pharmaceuticals & Health Care Research sector have seen a -23.1% change in market cap over the last 12 months. Investors have become pessimistic on the sector couple with macroeconomic factors that might be strong headwinds for the sector.

Most of the last 12 months in the Pharmaceuticals & Health Care Research sector has been negative with December (+2.8%), March (+2.1%) and June (+1.6%) being the best performing months.

Sector Valuation

Has the Pharmaceuticals & Health Care Research sector valuation in Indonesia changed over the past 12 months?

Price to Earnings Ratio

  • The Pharmaceuticals & Health Care Research sector is trading at a median PE ratio of 8.62x, which is lower than its 3-year historical average PE of 17.71x. This puts the sector in the undervalued category based on its historical valuation.
  • Companies in the Pharmaceuticals & Health Care Research have an extremely wide range of PE ratio, going between -109x to 24x.This makes it necessary to consider the outliers in the sector, and adjust for the respective market caps of each company to prevent any skewing of the data.
  • To add some perspective across the value disparity, among the top gainers in the last month, Kalbe Farma Tbk commands a premium with a PE ratio of 23.74 while PT Phapros Tbk is trading at a PE ratio of only -108.79.
  • When weighted by market cap, the Pharmaceuticals & Health Care Research sector is trading at a PE ratio of 17.71x as compared to the unweighted PE ratio of 8.62x. The unweighted sector median is a valuation that is largely on par with the overall IDX median of 8.22x.
  • The Pharmaceuticals & Health Care Research sector is trading at a PE ratio (8.62) that represents a substantial discount to its historical average (19.27).

Sector Gainers

KAEF Logo
Kimia Farma Tbk.
KAEF.JK
Last Trading Day

IDR 925.00

1 Month

+12.12%

1 Year

-0.54%

P/E Ratio

-30.93

IKPM Logo
PT Ikapharmindo Putramas Tbk.
IKPM.JK
Last Trading Day

IDR 292.00

1 Month

+10.61%

PEHA Logo
PT Phapros Tbk
PEHA.JK
Last Trading Day

IDR 545.00

1 Month

+5.83%

1 Year

-18.05%

P/E Ratio

-108.79

KLBF Logo
Kalbe Farma Tbk
KLBF.JK
Last Trading Day

IDR 1,520.00

1 Month

+3.05%

1 Year

-28.64%

P/E Ratio

23.74

SOHO Logo
PT Soho Global Health Tbk
SOHO.JK
Last Trading Day

IDR 496.00

1 Month

+1.22%

1 Year

-4.62%

P/E Ratio

18.57